📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CureDM

1.1 - Company Overview

CureDM Logo

CureDM

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical therapies that may prevent, ameliorate or reverse diabetes, including Human proIslet Peptide (HIP), a novel human peptide developed to regenerate insulin-producing islets in the pancreas and potentially restore pancreatic function without stem cells, with the goal of allowing discontinuation of insulin.

Products and services

  • Diabetes Reversal Therapies: CureDM develops biopharmaceutical therapies to reverse diabetes, aiming to allow the discontinuation of insulin in patients
  • Diabetes Prevention Therapies: CureDM engineers new biopharmaceutical therapies intended to prevent diabetes, reflecting its mission to develop treatments that may forestall disease
  • Human proIslet Peptide (HIP): A human-derived peptide engineered to regenerate insulin-producing pancreatic islets, potentially restoring pancreatic function in diabetes without using stem cells

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CureDM

Modulim Logo

Modulim

HQ: United States Website
  • Description: Provider of light-based imaging and care management solutions: Clarifi Imaging System, a non-contact, noninvasive tool using spatial frequency domain imaging to assess microvascular health by measuring tissue oxygenation and perfusion; LAMP, integrating patient assessment, data management, and care coordination; Modulim Cloud, a HIPAA-compliant platform for secure data and imaging; and Magnifi Software for tailored views and remote care collaboration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Modulim company profile →
Generex Logo

Generex

HQ: United States Website
  • Description: Provider of drug delivery systems and technologies for metabolic and immunological diseases, developing and commercializing these offerings.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Generex company profile →
Adocia Logo

Adocia

HQ: France Website
  • Description: Provider of biotechnology therapies specializing in tissue regeneration and diabetes treatments, developing medicines with already-approved therapeutic proteins. Offerings include BioChaperone Lispro ultra-rapid insulin, BioChaperone Combo glargine+lispro, AdoShell Islets hydrogel implant, M1Pram and BioChaperone LisPram co-formulations, and AdOral Sema oral semaglutide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adocia company profile →
Medicore Logo

Medicore

HQ: United States Website
  • Description: Provider of blood collection and diabetic care products, manufacturing and distributing to hospitals and medical companies. Holds multiple contracts with hospital group purchasing organizations, with product line available through nearly all major medical device distributors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medicore company profile →
TypeZero Logo

TypeZero

HQ: United States Website
  • Description: Provider of digital health and personalized medicine focused on the treatment and management of diabetes, leveraging more than 10 years of clinical trials, research, and innovation to develop the inControl Diabetes Management Platform to improve and simplify the lives of people with diabetes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TypeZero company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CureDM

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CureDM

2.2 - Growth funds investing in similar companies to CureDM

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CureDM

4.2 - Public trading comparable groups for CureDM

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CureDM

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CureDM

What does CureDM do?

CureDM is a provider of biopharmaceutical therapies that may prevent, ameliorate or reverse diabetes, including Human proIslet Peptide (HIP), a novel human peptide developed to regenerate insulin-producing islets in the pancreas and potentially restore pancreatic function without stem cells, with the goal of allowing discontinuation of insulin.

Who are CureDM's competitors?

CureDM's competitors and similar companies include Modulim, Generex, Adocia, Medicore, and TypeZero.

Where is CureDM headquartered?

CureDM is headquartered in United States.

How many employees does CureDM have?

CureDM has 1,000 employees 🔒.

When was CureDM founded?

CureDM was founded in 2010 🔒.

What sector and industry vertical is CureDM in?

CureDM is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CureDM

Who are the top strategic acquirers in CureDM's sector and industry

Top strategic M&A buyers and acquirers in CureDM's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CureDM?

Top strategic M&A buyers groups and sectors for CureDM include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CureDM's sector and industry vertical

Which are the top PE firms investing in CureDM's sector and industry vertical?

Top PE firms investing in CureDM's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CureDM's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CureDM's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CureDM's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CureDM include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CureDM's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CureDM?

The key public trading comparables and valuation benchmarks for CureDM include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CureDM for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CureDM with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CureDM's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CureDM with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CureDM's' sector and industry vertical?

Access recent funding rounds and capital raises in CureDM's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CureDM